AITX Authorizes 3.8 Billion New Shares Amidst Pending Reverse Split, Signaling Future Dilution

summarizeSummary

Artificial Intelligence Technology Solutions Inc. has authorized an additional 3.8 billion common shares, increasing its total authorized stock to 31.3 billion, a move intended to support future financing and meet conversion obligations, but which carries significant dilution risk, especially if its pending reverse stock split is denied.

check_boxKey Events · Corporate Governance and Compliance · AITX

• Authorized Share Increase Approved

  Shareholders approved an increase of 3.8 billion common shares, raising the total authorized common stock from 27.5 billion to 31.3 billion shares. This action was approved by written consent on February 19, 2026.

• Purpose for Future Financing

  The increase is intended to provide flexibility for future financing opportunities, meet contractual conversion obligations for Series C and F Preferred holders, and support the SARA platform expansion.

• Significant Dilution Risk Highlighted

  The company explicitly warns of "disproportionate dilution" if the authorized share increase becomes effective but the pending 1-for-100 reverse stock split, filed on February 17, 2026, is denied by FINRA.

• CEO-Controlled Approval

  The action was approved by written consent from CEO Steve Reinharz, who holds 67.7% of the company's voting power through Series E Preferred Stock.

auto_awesomeAnalysis · AITX · Technology

This preliminary information statement details Artificial Intelligence Technology Solutions Inc.'s approval to significantly increase its authorized common stock by 3.8 billion shares. This action, approved by the CEO who controls a majority of voting power, is a critical step for AITX to secure future capital and manage existing convertible obligations, particularly given its previously disclosed "going concern" issues and reliance on dilutive financing. While intended to be coordinated with a pending 1-for-100 reverse stock split, the filing explicitly warns of "disproportionate dilution" if the authorized share increase becomes effective but the reverse split is denied by FINRA, as the newly authorized shares would then be available against the current, much larger, outstanding share count. This move signals a high likelihood of substantial future dilution for existing shareholders as the company seeks to shore up its financial position.